Global Health Limited (Medanta) has submitted a regulatory disclosure to both BSE Limited and National Stock Exchange of India Limited regarding an upcoming board meeting.
The Board of Directors meeting is scheduled for Thursday, July 30, 2026. The primary agenda item is to consider and approve the company's Unaudited Financial Results for the first quarter ended June 30, 2026.
In compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015 and the company's internal Code for prevention of Insider Trading, the Trading Window has been closed since July 1, 2026. The trading restrictions will remain in effect and will only reopen after 48 hours from the declaration of the Q1 FY2027 financial results.
The disclosure was signed by Rahul Ranjan, Company Secretary & Compliance Officer (Membership No. A17035), on July 20, 2026 at 17:03:54 IST. The communication serves as formal intimation under Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.